 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper130th MAINE LEGISLATURE
FIRST  SPECIAL  SESSION-2021
Legislative Document No. 1428
H.P. 1044 House of  Representatives,  April 12, 2021
An Act  To Increase the Availability  of Nasal Naloxone in 
Community Settings
Received by the Clerk of the House on April  8, 2021.  Referred to  the Committee  on Health 
and Human Services pursuant to Joint Rule 308.2 and  ordered  printed pursuant to  Joint  Rule 
401.
ROBERT  B. HUNT
Clerk
Presented by Representative DODGE of Belfast.
Cosponsored by Representatives:  BRENNAN of  Portland, HARNETT of  Gardiner,  
MADIGAN of Waterville, MORALES of South  Portland,  STOVER of Boothbay, TEPLER  of 
Topsham, ZAGER of Portland,  Senator: RAFFERTY of York.

Page 1 - 130LR1626(01)1Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  22 MRSA ยง2353, sub-ยง4-B is enacted to read:
34-B.  Community organizations; standing orders for nasal naloxone 
4hydrochloride.  If a community organization opts to possess and administer nasal naloxone 
5 hydrochloride at the community organization's facility, acting under standing orders from 
6 a licensed health care professional authorized by law to prescribe nasal naloxone 
7 hydrochloride, the community organization shall operate in accordance with rules adopted 
8 by the department and the provisions of this subsection.
9 A.  Notwithstanding any provision of law to the contrary, a community organization 
10 may store at the organization's facility and dispense nasal naloxone hydrochloride and 
11 is not subject to the provisions of Title 32, chapter 117.
12 B.  A community organization shall obtain training in administration of nasal naloxone 
13 hydrochloride that meets the protocols and criteria established by the department.  A 
14 community organization may seek out an appropriate training entity to train the 
15 organization's employees in the administration of nasal naloxone hydrochloride and 
16 overdose identification and prevention.  Employees of the community organization 
17 who administer nasal naloxone hydrochloride and all other persons involved in the 
18 administration of the community organization shall successfully complete the training 
19 and possess documentation of having successfully completed the training from the 
20 training entity or community organization that conducted the training.
21 C.  A syringe services program certified by the Maine Center for Disease Control and 
22 Prevention or other entity that provides nasal naloxone hydrochloride shall provide 
23 unit-of-use packages of nasal naloxone hydrochloride to a community organization that 
24 has provided training described in paragraph B so that the community organization 
25 may possess and administer nasal naloxone hydrochloride to an individual who appears 
26 to be experiencing a drug-related overdose.
27 D. For purposes of this subsection, unless the context otherwise indicates, "community 
28 organization" means a private or nonprofit organization operating a facility that serves 
29 the community.
30 The department shall adopt rules to implement this subsection.  Rules adopted pursuant to 
31 this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 
32 2-A.
33SUMMARY
34 This bill allows community organizations, which are defined as private or nonprofit 
35 organizations operating a facility that serves the community, to store and administer nasal 
36 naloxone hydrochloride upon a standing order from a licensed health care professional 
37 authorized by law to prescribe nasal naloxone hydrochloride.34
35
36
37
